Evidence of overdiagnosis

Evidence of overdiagnosis

Sandblom and colleagues' paper compared the case fatality rate of prostate cancer between men randomly assigned to screening and those who were not invited for screening. 1 A more reliable outcome of such a randomised controlled trial is the difference of mortality as a result of prostate cance...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:BMJ 2011-06, Vol.342 (7811), p.1326-1326
Hauptverfasser: Junod, Bernard, Kaplan, Robert M, Foucras, Philippe, Dupagne, Dominique, Nicot, Philippe
Format: Artikel
Sprache:eng
Schlagworte:
Fatalities
Humans
Male
Medical prognosis
Medical screening
Prostate cancer
PROSTATE CANCER SCREENING
Prostatic Neoplasms - diagnosis
Survival analysis
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1326
container_issue 7811
container_start_page 1326
container_title BMJ
container_volume 342
creator Junod, Bernard
Kaplan, Robert M
Foucras, Philippe
Dupagne, Dominique
Nicot, Philippe
description Sandblom and colleagues' paper compared the case fatality rate of prostate cancer between men randomly assigned to screening and those who were not invited for screening. 1 A more reliable outcome of such a randomised controlled trial is the difference of mortality as a result of prostate cancer between intervention...
doi_str_mv 10.1136/bmj.d3700
format Article
fullrecord <record><control><sourceid>jstor_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_872129341</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><jstor_id>23049997</jstor_id><sourcerecordid>23049997</sourcerecordid><originalsourceid>FETCH-LOGICAL-b276t-8c9d4351b35db819cfb6444165719655744f3aa1f66c7ad456730ffed69d6a013</originalsourceid><addsrcrecordid>eNp10M1LwzAYBvAgihtzB48eFEFBPHQmzVdzlDI_YEyE6cFLSJtUWtd2Ju3Q_97UzgmCpxyeH-_75gHgEMEJQphdJWUx0ZhDuAOGiLAooBHGu2AIBRVBhHA0AGPnCghhiHkkGN0HgxAxHgouhuBous61qVJzWmen9dpYnavXqna5OwB7mVo6M968I_B0M13Ed8Hs4fY-vp4FSchZE0Sp0ARTlGCqkwiJNEsYIQQxypFfRjkhGVYKZYylXGlCGccwy4xmQjMFER6Bi37uytbvrXGNLHOXmuVSVaZunYx4iEKBSSfP_siibm3lj5NIIMiZ4Ix4ddmr1NbOWZPJlc1LZT8lgrJrTPrG5Hdj3p5sJrZJafRW_vTjwXEPCtfU9jfHkAghuM-DPs9dYz62ubJv0v-TUzl_jiWGj3Axf4ll5897393w_11fI3iHRA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1910769764</pqid></control><display><type>article</type><title>Evidence of overdiagnosis</title><source>Jstor Complete Legacy</source><source>MEDLINE</source><source>BMJ Journals - NESLi2</source><creator>Junod, Bernard ; Kaplan, Robert M ; Foucras, Philippe ; Dupagne, Dominique ; Nicot, Philippe</creator><creatorcontrib>Junod, Bernard ; Kaplan, Robert M ; Foucras, Philippe ; Dupagne, Dominique ; Nicot, Philippe</creatorcontrib><description>Sandblom and colleagues' paper compared the case fatality rate of prostate cancer between men randomly assigned to screening and those who were not invited for screening. 1 A more reliable outcome of such a randomised controlled trial is the difference of mortality as a result of prostate cancer between intervention...</description><identifier>ISSN: 0959-8138</identifier><identifier>EISSN: 1468-5833</identifier><identifier>EISSN: 1756-1833</identifier><identifier>DOI: 10.1136/bmj.d3700</identifier><identifier>PMID: 21672979</identifier><language>eng</language><publisher>England: British Medical Journal Publishing Group</publisher><subject>Fatalities ; Humans ; Male ; Medical prognosis ; Medical screening ; Prostate cancer ; PROSTATE CANCER SCREENING ; Prostatic Neoplasms - diagnosis ; Survival analysis</subject><ispartof>BMJ, 2011-06, Vol.342 (7811), p.1326-1326</ispartof><rights>BMJ Publishing Group Ltd 2011</rights><rights>Copyright: 2011 © BMJ Publishing Group Ltd 2011</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttp://bmj.com/content/342/bmj.d3700.full.pdf$$EPDF$$P50$$Gbmj$$H</linktopdf><linktohtml>$$Uhttp://bmj.com/content/342/bmj.d3700.full$$EHTML$$P50$$Gbmj$$H</linktohtml><link.rule.ids>114,115,314,776,780,799,3183,23550,27901,27902,57992,58225,77343,77374</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21672979$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Junod, Bernard</creatorcontrib><creatorcontrib>Kaplan, Robert M</creatorcontrib><creatorcontrib>Foucras, Philippe</creatorcontrib><creatorcontrib>Dupagne, Dominique</creatorcontrib><creatorcontrib>Nicot, Philippe</creatorcontrib><title>Evidence of overdiagnosis</title><title>BMJ</title><addtitle>BMJ</addtitle><description>Sandblom and colleagues' paper compared the case fatality rate of prostate cancer between men randomly assigned to screening and those who were not invited for screening. 1 A more reliable outcome of such a randomised controlled trial is the difference of mortality as a result of prostate cancer between intervention...</description><subject>Fatalities</subject><subject>Humans</subject><subject>Male</subject><subject>Medical prognosis</subject><subject>Medical screening</subject><subject>Prostate cancer</subject><subject>PROSTATE CANCER SCREENING</subject><subject>Prostatic Neoplasms - diagnosis</subject><subject>Survival analysis</subject><issn>0959-8138</issn><issn>1468-5833</issn><issn>1756-1833</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNp10M1LwzAYBvAgihtzB48eFEFBPHQmzVdzlDI_YEyE6cFLSJtUWtd2Ju3Q_97UzgmCpxyeH-_75gHgEMEJQphdJWUx0ZhDuAOGiLAooBHGu2AIBRVBhHA0AGPnCghhiHkkGN0HgxAxHgouhuBous61qVJzWmen9dpYnavXqna5OwB7mVo6M968I_B0M13Ed8Hs4fY-vp4FSchZE0Sp0ARTlGCqkwiJNEsYIQQxypFfRjkhGVYKZYylXGlCGccwy4xmQjMFER6Bi37uytbvrXGNLHOXmuVSVaZunYx4iEKBSSfP_siibm3lj5NIIMiZ4Ix4ddmr1NbOWZPJlc1LZT8lgrJrTPrG5Hdj3p5sJrZJafRW_vTjwXEPCtfU9jfHkAghuM-DPs9dYz62ubJv0v-TUzl_jiWGj3Axf4ll5897393w_11fI3iHRA</recordid><startdate>20110614</startdate><enddate>20110614</enddate><creator>Junod, Bernard</creator><creator>Kaplan, Robert M</creator><creator>Foucras, Philippe</creator><creator>Dupagne, Dominique</creator><creator>Nicot, Philippe</creator><general>British Medical Journal Publishing Group</general><general>BMJ Publishing Group</general><general>BMJ Publishing Group LTD</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88I</scope><scope>8AF</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ASE</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FPQ</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>K6X</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M2O</scope><scope>M2P</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20110614</creationdate><title>Evidence of overdiagnosis</title><author>Junod, Bernard ; Kaplan, Robert M ; Foucras, Philippe ; Dupagne, Dominique ; Nicot, Philippe</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b276t-8c9d4351b35db819cfb6444165719655744f3aa1f66c7ad456730ffed69d6a013</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Fatalities</topic><topic>Humans</topic><topic>Male</topic><topic>Medical prognosis</topic><topic>Medical screening</topic><topic>Prostate cancer</topic><topic>PROSTATE CANCER SCREENING</topic><topic>Prostatic Neoplasms - diagnosis</topic><topic>Survival analysis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Junod, Bernard</creatorcontrib><creatorcontrib>Kaplan, Robert M</creatorcontrib><creatorcontrib>Foucras, Philippe</creatorcontrib><creatorcontrib>Dupagne, Dominique</creatorcontrib><creatorcontrib>Nicot, Philippe</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Index</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>British Nursing Index (BNI) (1985 to Present)</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection</collection><collection>British Nursing Index</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Research Library</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>BMJ</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Junod, Bernard</au><au>Kaplan, Robert M</au><au>Foucras, Philippe</au><au>Dupagne, Dominique</au><au>Nicot, Philippe</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Evidence of overdiagnosis</atitle><jtitle>BMJ</jtitle><addtitle>BMJ</addtitle><date>2011-06-14</date><risdate>2011</risdate><volume>342</volume><issue>7811</issue><spage>1326</spage><epage>1326</epage><pages>1326-1326</pages><issn>0959-8138</issn><eissn>1468-5833</eissn><eissn>1756-1833</eissn><abstract>Sandblom and colleagues' paper compared the case fatality rate of prostate cancer between men randomly assigned to screening and those who were not invited for screening. 1 A more reliable outcome of such a randomised controlled trial is the difference of mortality as a result of prostate cancer between intervention...</abstract><cop>England</cop><pub>British Medical Journal Publishing Group</pub><pmid>21672979</pmid><doi>10.1136/bmj.d3700</doi><tpages>1</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0959-8138
ispartof BMJ, 2011-06, Vol.342 (7811), p.1326-1326
issn 0959-8138
1468-5833
1756-1833
language eng
recordid cdi_proquest_miscellaneous_872129341
source Jstor Complete Legacy; MEDLINE; BMJ Journals - NESLi2
subjects Fatalities
Humans
Male
Medical prognosis
Medical screening
Prostate cancer
PROSTATE CANCER SCREENING
Prostatic Neoplasms - diagnosis
Survival analysis
title Evidence of overdiagnosis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T21%3A47%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-jstor_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Evidence%20of%20overdiagnosis&rft.jtitle=BMJ&rft.au=Junod,%20Bernard&rft.date=2011-06-14&rft.volume=342&rft.issue=7811&rft.spage=1326&rft.epage=1326&rft.pages=1326-1326&rft.issn=0959-8138&rft.eissn=1468-5833&rft_id=info:doi/10.1136/bmj.d3700&rft_dat=%3Cjstor_proqu%3E23049997%3C/jstor_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1910769764&rft_id=info:pmid/21672979&rft_jstor_id=23049997&rfr_iscdi=true